Reticuline (Isoquinoline Alkaloid · Morphine Biosynthetic Precursor · Research Reference)
| Compound | Reticuline ((R/S)-Reticuline; 1-Benzyl-2-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diol) |
| Class | Alkaloid — Isoquinoline (Benzylisoquinoline — BTIQ) |
| CAS | 18797-79-0 |
| Molecular formula | C₁₉H₂₃NO₄ |
| Primary sources | Papaver somniferum, Cocculus laurifolius, various Berberis spp. |
| Plant part | Capsule latex, roots |
| Claim strength | Emerging |
| Key applications | Biosynthetic precursor (morphine pathway); metabolic engineering; CNS receptor pharmacology; informational-only |
| Buy from Herbuno | Informational reference — see HerbIQ Compound Index → |
Name origin: Reticuline is named after Cocculus laurifolius (reticulatus = net-veined), from which it was first isolated as a pure compound. It is, however, far more biosynthetically significant in Papaver somniferum, where (R)-reticuline is the branching intermediate that determines whether the plant produces morphinan alkaloids (morphine, codeine) or benzophenanthridine alkaloids (sanguinarine) depending on downstream enzyme activity. Traditional use: Reticuline has no independent traditional medicinal use. Its significance is wholly as a biosynthetic intermediate — the key branch-point compound in the morphine alkaloid pathway. Research trajectory: Reticuline gained enormous research importance after Facchini, Smolke, and others identified the reticuline epimerisation step (R→S conversion via 1,2-dehydroreticulinium) as a key bottleneck in the microbial biosynthesis of opioids. Reconstituting this step in yeast (Saccharomyces cerevisiae) was the critical advance enabling complete microbial biosynthesis of morphine and hydrocodone from sugar — the landmark Galanie et al. 2015 Science paper. Safety context: Reticuline has mild CNS pharmacological activity (mu and kappa opioid receptor partial agonism reported at micromolar concentrations) but is not a controlled substance. It is of greatest relevance to pharmaceutical biotechnology.
Biosynthetic and Pharmacological Profile of Reticuline
Central morphine biosynthetic role: (S)-Reticuline is the last branch-point intermediate before the morphinan alkaloid pathway diverges irreversibly toward morphine production. The enzyme salutaridine synthase (a cytochrome P450) converts (S)-reticuline to salutaridine — the first committed step toward morphine. This makes reticuline the critical compound for understanding and engineering the morphine biosynthetic pathway in plants and microorganisms. Claim strength: High (biochemistry).
Metabolic engineering milestone: The 2015 Galanie et al. Science paper demonstrated complete yeast biosynthesis of opioids from glucose by reconstituting the entire 15-enzyme pathway from (R)-reticuline through to morphine and hydrocodone. The reticuline epimerisation step — converting plant-synthesised (R)-reticuline to (S)-reticuline via 1,2-dehydroreticulinium ion — was the last missing piece. This represents one of the most complex natural product biosynthetic pathways reconstituted in a heterologous host. Claim strength: High (biochemistry).
CNS pharmacological activity: Reticuline has been characterised as a partial agonist at mu and kappa opioid receptors with weak dopaminergic effects. In rodent models, modest antinociceptive activity has been reported at high doses. The pharmacological significance at naturally occurring concentrations is minimal. Claim strength: Emerging.
Anti-inflammatory and neuroprotective: Several in vitro studies have characterised anti-inflammatory (NF-κB inhibition) and neuroprotective (against oxidative stress-induced neuronal death) activities for reticuline at 10–100 μM concentrations. The clinical relevance of these findings is distant. Claim strength: Emerging.
This compound is documented for research and formulator education purposes. For commercially available botanical ingredients, explore the HerbIQ Compound Index →
Research and Formulator Context
Reticuline is a research chemical of significant importance to pharmaceutical biotechnology — specifically to the field of biosynthetic opioid production and plant secondary metabolite engineering. It is not a supplement, food additive, or commercial botanical extract target.
The biosynthetic significance of reticuline positions it as an important reference compound for formulators seeking to understand the full chemical ecology of Papaver somniferum and the alkaloid families derived from this plant. Understanding where reticuline sits in the biosynthetic cascade explains the co-occurrence of berberine-type alkaloids (which diverge before reticuline), morphinan alkaloids (which diverge at reticuline), and benzophenanthridine alkaloids (sanguinarine — also diverging at reticuline) in different plant species.
Reticuline is available as an analytical reference standard from specialist suppliers for research purposes. It is not independently scheduled in most jurisdictions but may be subject to precursor controls in countries with broad Papaver alkaloid regulations.
This entry completes the reticuline position in the HerbIQ Papaver alkaloid biosynthetic series, providing formulator context for the chemical diversity of one of pharmacy's most important plant species.
Frequently Asked Questions — Reticuline
What is reticuline's role in the morphine biosynthetic pathway?
(S)-Reticuline is the last branch-point intermediate before irreversible commitment to morphinan alkaloid production. Salutaridine synthase converts it to salutaridine, leading to thebaine, codeine, and morphine. If reticuline takes a different enzymatic route (via scoulerine synthase), it leads instead to berberine and benzophenanthridine alkaloids. The plant's complement of P450 enzymes at this branch determines which alkaloid series it produces.
Why was reticuline critical to the achievement of full yeast biosynthesis of opioids?
The yeast biosynthesis effort (Galanie et al. 2015, Science) required reconstituting the plant's 15-enzyme morphine pathway. The key bottleneck was the epimerisation of (R)-reticuline (the form initially produced by yeast) to (S)-reticuline (the form needed for morphine synthesis). This required two plant enzymes — reticuline oxidase and 1,2-dehydroreticuline reductase — whose characterisation and yeast expression completed the pathway.
Does reticuline have any pharmacological activity itself?
Reticuline has weak partial opioid receptor agonism and modest anti-inflammatory activity in vitro, but its concentrations in any plant preparation are far below pharmacologically active thresholds. It is not a compound with clinically relevant independent pharmacology; its significance is biosynthetic and biochemical.
Is reticuline found in berberine-containing plants like Berberis?
Yes — reticuline is a common BTIQ intermediate in multiple plant families. In Berberis and Hydrastis, it branches toward berberine and canadine via scoulerine rather than toward morphine. This is why berberine plants and Papaver plants share early biosynthetic steps (from tyrosine to norcoclaurine to reticuline) before diverging at the reticuline branch point.
Related compounds: Laudanosine, Berberine, Sanguinarine, Cryptopine
Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.
← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery